Speaker: Dr. Nick Hutchinson is the Business Steering Group Leader for Mammalian Cell Culture at FUJIFILM Diosynth Biotechnologies (FDB). He has global responsibility for leading the design of new mammalian cell culture services and evaluating investments in new manufacturing capacity. Prior to this role he led FDB’s streamlined monoclonal antibody development and manufacturing services, which included process development and process transfer to FDB’s GMP manufacturing site for early phase clients. He has previously worked for another contract manufacturing organization as a research engineer, developing novel methods for large-scale antibody purification and transferring manufacturing processes from a UK manufacturing location to large-scale facilities in the USA, Spain and Singapore. He has also held marketing-related positions with Thermo Fisher Scientific, Sartorius Stedim Biotech and Parker Hannifin. Dr. Hutchinson received a Biochemical Engineering Doctorate from University College London and an MBA from Durham University.
Speaker: Dr. Janice Reichert is an internationally-recognized expert in the development of antibody therapeutics. She is Executive Director of The Antibody Society, a non-profit association representing individuals and organizations that engage in antibody research or development. Dr. Reichert is also Founder and Editor-in-Chief of mAbs, a peer-reviewed, PubMed-indexed biomedical journal that focuses on topics relevant to antibody research and development, and Founder and Managing Director of Reichert Biotechnology Consulting LLC, a pharmaceutical business intelligence research firm. Dr. Reichert writes frequently on development trends for antibody therapeutics, including the annual ‘Antibodies to watch’ articles published in mAbs, and she has presented her research results as an invited speaker at conferences held worldwide. Dr. Reichert received a PhD from the University of Pennsylvania and post-doctoral training at Harvard Medical School.
Kaplon et al. Antibodies to Watch in 2020. mAbs 2020.
Hutchinson N. Tracking Therapeutic Antibody Development in a Pandemic. BioProcess International. October 2020.
COVID-19 Biologics Tracker